Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
-- Patent eligible for Orange Book listing will provide additional protection into 2041 -- TAMPA, Fla., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry...
-
Pursuant to its U.S. Patent Application No. 17/204,106 NEW YORK, NY, Nov. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a...
-
San Francisco, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Today, Ankr, a leader in the digital asset space as a software platform and decentralized infrastructure provider, introduced Ankr V2, a...
-
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCHD) ("GBT” or the “Company”), filed with the U.S. Patent and Trademark Office (“USPTO”) a provisional patent, USPTO...
-
Mount Vernon, New York, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Key Digital to Present Comprehensive Video Processing, Distribution and AV over IP Solutions at InfoComm 2021 MOUNT VERNON, NY,...
-
This platform is the technology that supports interoperability and provides the integration of all of CloudMD’s healthcare capabilitiesPlatform is trusted by various local, state and federal agencies...
-
JATENZO® (testosterone undecanoate) is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in adult males who have deficient testosterone due to certain medical...
-
NEWTON, Mass. and GENEVA, Switzerland, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF,...
-
LONDON, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies,...
-
WARRINGTON, Pa., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...